share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dhaliwal Jatinder

Virpax製藥 | 4：持股變動聲明-董事 Dhaliwal Jatinder
美股sec公告 ·  07/09 16:06
Moomoo AI 已提取核心訊息
In a recent transaction, Jatinder Dhaliwal, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on July 5, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The number of shares held by Dhaliwal after the transaction is also undisclosed. This information is critical for investors monitoring insider activity and gauging market sentiment towards Virpax Pharmaceuticals.
In a recent transaction, Jatinder Dhaliwal, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on July 5, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, have not been disclosed. The number of shares held by Dhaliwal after the transaction is also undisclosed. This information is critical for investors monitoring insider activity and gauging market sentiment towards Virpax Pharmaceuticals.
最近，維爾帕克斯藥品公司（VRPX）的相關人員賈廷德·達利瓦爾（Jatinder Dhaliwal）在2024年7月5日進行了股票交易。交易的具體細節，包括涉及的股份數量、股份性質、交易價格以及股份的總價值都尚未披露。達利瓦爾交易後持有的股份數量也未公開。這些信息對於監控內幕交易及衡量市場對維爾帕克斯藥品公司看法的投資者來說至關重要。
最近，維爾帕克斯藥品公司（VRPX）的相關人員賈廷德·達利瓦爾（Jatinder Dhaliwal）在2024年7月5日進行了股票交易。交易的具體細節，包括涉及的股份數量、股份性質、交易價格以及股份的總價值都尚未披露。達利瓦爾交易後持有的股份數量也未公開。這些信息對於監控內幕交易及衡量市場對維爾帕克斯藥品公司看法的投資者來說至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息